.Pharmacolibrary.Drugs.ATC.L.L01DB09

Information

name:Valrubicin
ATC code:L01DB09
route:intravesical
compartments:1
dosage:800mg
volume of distribution:325L
clearance:78.6L/h
other parameters in model implementation

Valrubicin is a semisynthetic anthracycline derivative used as an antineoplastic agent, primarily for the intravesical treatment of Bacillus Calmette-Guerin (BCG)-refractory carcinoma in situ of the urinary bladder. It is approved for this indication and is not recommended for systemic administration.

Pharmacokinetics

Pharmacokinetic data are reported for adults with BCG-refractory carcinoma in situ of the bladder following intravesical administration.

References

    Revisions


    Generated at 2025-10-07T18:21:17Z by OpenModelicaOpenModelica 1.25.4 using GenerateDoc.mos